Drugs that are used on the body surface or on certain mucous membranes to kill insects and relieve itching, reduce swelling and dissipate stagnation, dissipate putrefaction and discharge pus, promote muscle growth and mouth opening, and astringe and stop bleeding are called external medicines.
The global market for Drugs for External Use is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drugs for External Use market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drugs for External Use market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drugs for External Use market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drugs for External Use market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drugs for External Use players cover Yunnan Baiyao, Linrui, Cheezheng, Shengyang Hongyao and Yulin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drugs for External Use market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drugs for External Use market, with both quantitative and qualitative data, to help readers understand how the Drugs for External Use market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Drugs for External Use market and forecasts the market size by Type (Lotion, Ointment and Tincture), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Lotion
Ointment
Tincture
Other
Segmentation by application
Hospital
Clinic
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Yunnan Baiyao
Linrui
Cheezheng
Shengyang Hongyao
Yulin
Huahong Pharma
LKF
Hubiao
GSK
Tianhe
Wantong Group
Hisamitsu
MUHI
JNJ
Chapter Introduction
Chapter 1: Scope of Drugs for External Use, Research Methodology, etc.
Chapter 2: Executive Summary, global Drugs for External Use market size (sales and revenue) and CAGR, Drugs for External Use market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drugs for External Use sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drugs for External Use sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drugs for External Use market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Yunnan Baiyao, Linrui, Cheezheng, Shengyang Hongyao, Yulin, Huahong Pharma, LKF, Hubiao and GSK, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for External Use Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drugs for External Use by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drugs for External Use by Country/Region, 2017, 2022 & 2028
2.2 Drugs for External Use Segment by Type
2.2.1 Lotion
2.2.2 Ointment
2.2.3 Tincture
2.2.4 Other
2.3 Drugs for External Use Sales by Type
2.3.1 Global Drugs for External Use Sales Market Share by Type (2017-2022)
2.3.2 Global Drugs for External Use Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drugs for External Use Sale Price by Type (2017-2022)
2.4 Drugs for External Use Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Drugs for External Use Sales by Application
2.5.1 Global Drugs for External Use Sale Market Share by Application (2017-2022)
2.5.2 Global Drugs for External Use Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drugs for External Use Sale Price by Application (2017-2022)
3 Global Drugs for External Use by Company
3.1 Global Drugs for External Use Breakdown Data by Company
3.1.1 Global Drugs for External Use Annual Sales by Company (2020-2022)
3.1.2 Global Drugs for External Use Sales Market Share by Company (2020-2022)
3.2 Global Drugs for External Use Annual Revenue by Company (2020-2022)
3.2.1 Global Drugs for External Use Revenue by Company (2020-2022)
3.2.2 Global Drugs for External Use Revenue Market Share by Company (2020-2022)
3.3 Global Drugs for External Use Sale Price by Company
3.4 Key Manufacturers Drugs for External Use Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for External Use Product Location Distribution
3.4.2 Players Drugs for External Use Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drugs for External Use by Geographic Region
4.1 World Historic Drugs for External Use Market Size by Geographic Region (2017-2022)
4.1.1 Global Drugs for External Use Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drugs for External Use Annual Revenue by Geographic Region
4.2 World Historic Drugs for External Use Market Size by Country/Region (2017-2022)
4.2.1 Global Drugs for External Use Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drugs for External Use Annual Revenue by Country/Region
4.3 Americas Drugs for External Use Sales Growth
4.4 APAC Drugs for External Use Sales Growth
4.5 Europe Drugs for External Use Sales Growth
4.6 Middle East & Africa Drugs for External Use Sales Growth
5 Americas
5.1 Americas Drugs for External Use Sales by Country
5.1.1 Americas Drugs for External Use Sales by Country (2017-2022)
5.1.2 Americas Drugs for External Use Revenue by Country (2017-2022)
5.2 Americas Drugs for External Use Sales by Type
5.3 Americas Drugs for External Use Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for External Use Sales by Region
6.1.1 APAC Drugs for External Use Sales by Region (2017-2022)
6.1.2 APAC Drugs for External Use Revenue by Region (2017-2022)
6.2 APAC Drugs for External Use Sales by Type
6.3 APAC Drugs for External Use Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drugs for External Use by Country
7.1.1 Europe Drugs for External Use Sales by Country (2017-2022)
7.1.2 Europe Drugs for External Use Revenue by Country (2017-2022)
7.2 Europe Drugs for External Use Sales by Type
7.3 Europe Drugs for External Use Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for External Use by Country
8.1.1 Middle East & Africa Drugs for External Use Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drugs for External Use Revenue by Country (2017-2022)
8.2 Middle East & Africa Drugs for External Use Sales by Type
8.3 Middle East & Africa Drugs for External Use Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for External Use
10.3 Manufacturing Process Analysis of Drugs for External Use
10.4 Industry Chain Structure of Drugs for External Use
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drugs for External Use Distributors
11.3 Drugs for External Use Customer
12 World Forecast Review for Drugs for External Use by Geographic Region
12.1 Global Drugs for External Use Market Size Forecast by Region
12.1.1 Global Drugs for External Use Forecast by Region (2023-2028)
12.1.2 Global Drugs for External Use Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drugs for External Use Forecast by Type
12.7 Global Drugs for External Use Forecast by Application
13 Key Players Analysis
13.1 Yunnan Baiyao
13.1.1 Yunnan Baiyao Company Information
13.1.2 Yunnan Baiyao Drugs for External Use Product Offered
13.1.3 Yunnan Baiyao Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Yunnan Baiyao Main Business Overview
13.1.5 Yunnan Baiyao Latest Developments
13.2 Linrui
13.2.1 Linrui Company Information
13.2.2 Linrui Drugs for External Use Product Offered
13.2.3 Linrui Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Linrui Main Business Overview
13.2.5 Linrui Latest Developments
13.3 Cheezheng
13.3.1 Cheezheng Company Information
13.3.2 Cheezheng Drugs for External Use Product Offered
13.3.3 Cheezheng Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cheezheng Main Business Overview
13.3.5 Cheezheng Latest Developments
13.4 Shengyang Hongyao
13.4.1 Shengyang Hongyao Company Information
13.4.2 Shengyang Hongyao Drugs for External Use Product Offered
13.4.3 Shengyang Hongyao Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Shengyang Hongyao Main Business Overview
13.4.5 Shengyang Hongyao Latest Developments
13.5 Yulin
13.5.1 Yulin Company Information
13.5.2 Yulin Drugs for External Use Product Offered
13.5.3 Yulin Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Yulin Main Business Overview
13.5.5 Yulin Latest Developments
13.6 Huahong Pharma
13.6.1 Huahong Pharma Company Information
13.6.2 Huahong Pharma Drugs for External Use Product Offered
13.6.3 Huahong Pharma Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Huahong Pharma Main Business Overview
13.6.5 Huahong Pharma Latest Developments
13.7 LKF
13.7.1 LKF Company Information
13.7.2 LKF Drugs for External Use Product Offered
13.7.3 LKF Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 LKF Main Business Overview
13.7.5 LKF Latest Developments
13.8 Hubiao
13.8.1 Hubiao Company Information
13.8.2 Hubiao Drugs for External Use Product Offered
13.8.3 Hubiao Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hubiao Main Business Overview
13.8.5 Hubiao Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Drugs for External Use Product Offered
13.9.3 GSK Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Tianhe
13.10.1 Tianhe Company Information
13.10.2 Tianhe Drugs for External Use Product Offered
13.10.3 Tianhe Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Tianhe Main Business Overview
13.10.5 Tianhe Latest Developments
13.11 Wantong Group
13.11.1 Wantong Group Company Information
13.11.2 Wantong Group Drugs for External Use Product Offered
13.11.3 Wantong Group Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Wantong Group Main Business Overview
13.11.5 Wantong Group Latest Developments
13.12 Hisamitsu
13.12.1 Hisamitsu Company Information
13.12.2 Hisamitsu Drugs for External Use Product Offered
13.12.3 Hisamitsu Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hisamitsu Main Business Overview
13.12.5 Hisamitsu Latest Developments
13.13 MUHI
13.13.1 MUHI Company Information
13.13.2 MUHI Drugs for External Use Product Offered
13.13.3 MUHI Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 MUHI Main Business Overview
13.13.5 MUHI Latest Developments
13.14 JNJ
13.14.1 JNJ Company Information
13.14.2 JNJ Drugs for External Use Product Offered
13.14.3 JNJ Drugs for External Use Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 JNJ Main Business Overview
13.14.5 JNJ Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Drugs for External Use Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drugs for External Use Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Lotion
Table 4. Major Players of Ointment
Table 5. Major Players of Tincture
Table 6. Major Players of Other
Table 7. Global Drugs for External Use Sales by Type (2017-2022) & (K Units)
Table 8. Global Drugs for External Use Sales Market Share by Type (2017-2022)
Table 9. Global Drugs for External Use Revenue by Type (2017-2022) & ($ million)
Table 10. Global Drugs for External Use Revenue Market Share by Type (2017-2022)
Table 11. Global Drugs for External Use Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Drugs for External Use Sales by Application (2017-2022) & (K Units)
Table 13. Global Drugs for External Use Sales Market Share by Application (2017-2022)
Table 14. Global Drugs for External Use Revenue by Application (2017-2022)
Table 15. Global Drugs for External Use Revenue Market Share by Application (2017-2022)
Table 16. Global Drugs for External Use Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Drugs for External Use Sales by Company (2020-2022) & (K Units)
Table 18. Global Drugs for External Use Sales Market Share by Company (2020-2022)
Table 19. Global Drugs for External Use Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Drugs for External Use Revenue Market Share by Company (2020-2022)
Table 21. Global Drugs for External Use Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Drugs for External Use Producing Area Distribution and Sales Area
Table 23. Players Drugs for External Use Products Offered
Table 24. Drugs for External Use Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drugs for External Use Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Drugs for External Use Sales Market Share Geographic Region (2017-2022)
Table 29. Global Drugs for External Use Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Drugs for External Use Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Drugs for External Use Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Drugs for External Use Sales Market Share by Country/Region (2017-2022)
Table 33. Global Drugs for External Use Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Drugs for External Use Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Drugs for External Use Sales by Country (2017-2022) & (K Units)
Table 36. Americas Drugs for External Use Sales Market Share by Country (2017-2022)
Table 37. Americas Drugs for External Use Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Drugs for External Use Revenue Market Share by Country (2017-2022)
Table 39. Americas Drugs for External Use Sales by Type (2017-2022) & (K Units)
Table 40. Americas Drugs for External Use Sales Market Share by Type (2017-2022)
Table 41. Americas Drugs for External Use Sales by Application (2017-2022) & (K Units)
Table 42. Americas Drugs for External Use Sales Market Share by Application (2017-2022)
Table 43. APAC Drugs for External Use Sales by Region (2017-2022) & (K Units)
Table 44. APAC Drugs for External Use Sales Market Share by Region (2017-2022)
Table 45. APAC Drugs for External Use Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Drugs for External Use Revenue Market Share by Region (2017-2022)
Table 47. APAC Drugs for External Use Sales by Type (2017-2022) & (K Units)
Table 48. APAC Drugs for External Use Sales Market Share by Type (2017-2022)
Table 49. APAC Drugs for External Use Sales by Application (2017-2022) & (K Units)
Table 50. APAC Drugs for External Use Sales Market Share by Application (2017-2022)
Table 51. Europe Drugs for External Use Sales by Country (2017-2022) & (K Units)
Table 52. Europe Drugs for External Use Sales Market Share by Country (2017-2022)
Table 53. Europe Drugs for External Use Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Drugs for External Use Revenue Market Share by Country (2017-2022)
Table 55. Europe Drugs for External Use Sales by Type (2017-2022) & (K Units)
Table 56. Europe Drugs for External Use Sales Market Share by Type (2017-2022)
Table 57. Europe Drugs for External Use Sales by Application (2017-2022) & (K Units)
Table 58. Europe Drugs for External Use Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Drugs for External Use Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Drugs for External Use Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Drugs for External Use Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Drugs for External Use Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Drugs for External Use Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Drugs for External Use Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Drugs for External Use Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Drugs for External Use Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Drugs for External Use
Table 68. Key Market Challenges & Risks of Drugs for External Use
Table 69. Key Industry Trends of Drugs for External Use
Table 70. Drugs for External Use Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Drugs for External Use Distributors List
Table 73. Drugs for External Use Customer List
Table 74. Global Drugs for External Use Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Drugs for External Use Sales Market Forecast by Region
Table 76. Global Drugs for External Use Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Drugs for External Use Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Drugs for External Use Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Drugs for External Use Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Drugs for External Use Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Drugs for External Use Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Drugs for External Use Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Drugs for External Use Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Drugs for External Use Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Drugs for External Use Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Drugs for External Use Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Drugs for External Use Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Drugs for External Use Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Drugs for External Use Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Drugs for External Use Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Drugs for External Use Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Drugs for External Use Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Drugs for External Use Revenue Market Share Forecast by Application (2023-2028)
Table 94. Yunnan Baiyao Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 95. Yunnan Baiyao Drugs for External Use Product Offered
Table 96. Yunnan Baiyao Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Yunnan Baiyao Main Business
Table 98. Yunnan Baiyao Latest Developments
Table 99. Linrui Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 100. Linrui Drugs for External Use Product Offered
Table 101. Linrui Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Linrui Main Business
Table 103. Linrui Latest Developments
Table 104. Cheezheng Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 105. Cheezheng Drugs for External Use Product Offered
Table 106. Cheezheng Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Cheezheng Main Business
Table 108. Cheezheng Latest Developments
Table 109. Shengyang Hongyao Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 110. Shengyang Hongyao Drugs for External Use Product Offered
Table 111. Shengyang Hongyao Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Shengyang Hongyao Main Business
Table 113. Shengyang Hongyao Latest Developments
Table 114. Yulin Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 115. Yulin Drugs for External Use Product Offered
Table 116. Yulin Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Yulin Main Business
Table 118. Yulin Latest Developments
Table 119. Huahong Pharma Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 120. Huahong Pharma Drugs for External Use Product Offered
Table 121. Huahong Pharma Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Huahong Pharma Main Business
Table 123. Huahong Pharma Latest Developments
Table 124. LKF Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 125. LKF Drugs for External Use Product Offered
Table 126. LKF Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. LKF Main Business
Table 128. LKF Latest Developments
Table 129. Hubiao Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 130. Hubiao Drugs for External Use Product Offered
Table 131. Hubiao Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Hubiao Main Business
Table 133. Hubiao Latest Developments
Table 134. GSK Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 135. GSK Drugs for External Use Product Offered
Table 136. GSK Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. GSK Main Business
Table 138. GSK Latest Developments
Table 139. Tianhe Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 140. Tianhe Drugs for External Use Product Offered
Table 141. Tianhe Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Tianhe Main Business
Table 143. Tianhe Latest Developments
Table 144. Wantong Group Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 145. Wantong Group Drugs for External Use Product Offered
Table 146. Wantong Group Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Wantong Group Main Business
Table 148. Wantong Group Latest Developments
Table 149. Hisamitsu Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 150. Hisamitsu Drugs for External Use Product Offered
Table 151. Hisamitsu Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Hisamitsu Main Business
Table 153. Hisamitsu Latest Developments
Table 154. MUHI Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 155. MUHI Drugs for External Use Product Offered
Table 156. MUHI Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. MUHI Main Business
Table 158. MUHI Latest Developments
Table 159. JNJ Basic Information, Drugs for External Use Manufacturing Base, Sales Area and Its Competitors
Table 160. JNJ Drugs for External Use Product Offered
Table 161. JNJ Drugs for External Use Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. JNJ Main Business
Table 163. JNJ Latest Developments
List of Figures
Figure 1. Picture of Drugs for External Use
Figure 2. Drugs for External Use Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for External Use Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drugs for External Use Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drugs for External Use Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Lotion
Figure 10. Product Picture of Ointment
Figure 11. Product Picture of Tincture
Figure 12. Product Picture of Other
Figure 13. Global Drugs for External Use Sales Market Share by Type in 2021
Figure 14. Global Drugs for External Use Revenue Market Share by Type (2017-2022)
Figure 15. Drugs for External Use Consumed in Hospital
Figure 16. Global Drugs for External Use Market: Hospital (2017-2022) & (K Units)
Figure 17. Drugs for External Use Consumed in Clinic
Figure 18. Global Drugs for External Use Market: Clinic (2017-2022) & (K Units)
Figure 19. Drugs for External Use Consumed in Other
Figure 20. Global Drugs for External Use Market: Other (2017-2022) & (K Units)
Figure 21. Global Drugs for External Use Sales Market Share by Application (2017-2022)
Figure 22. Global Drugs for External Use Revenue Market Share by Application in 2021
Figure 23. Drugs for External Use Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Drugs for External Use Revenue Market Share by Company in 2021
Figure 25. Global Drugs for External Use Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Drugs for External Use Revenue Market Share by Geographic Region in 2021
Figure 27. Global Drugs for External Use Sales Market Share by Region (2017-2022)
Figure 28. Global Drugs for External Use Revenue Market Share by Country/Region in 2021
Figure 29. Americas Drugs for External Use Sales 2017-2022 (K Units)
Figure 30. Americas Drugs for External Use Revenue 2017-2022 ($ Millions)
Figure 31. APAC Drugs for External Use Sales 2017-2022 (K Units)
Figure 32. APAC Drugs for External Use Revenue 2017-2022 ($ Millions)
Figure 33. Europe Drugs for External Use Sales 2017-2022 (K Units)
Figure 34. Europe Drugs for External Use Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Drugs for External Use Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Drugs for External Use Revenue 2017-2022 ($ Millions)
Figure 37. Americas Drugs for External Use Sales Market Share by Country in 2021
Figure 38. Americas Drugs for External Use Revenue Market Share by Country in 2021
Figure 39. United States Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Drugs for External Use Sales Market Share by Region in 2021
Figure 44. APAC Drugs for External Use Revenue Market Share by Regions in 2021
Figure 45. China Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Drugs for External Use Sales Market Share by Country in 2021
Figure 52. Europe Drugs for External Use Revenue Market Share by Country in 2021
Figure 53. Germany Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Drugs for External Use Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Drugs for External Use Revenue Market Share by Country in 2021
Figure 60. Egypt Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Drugs for External Use Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Drugs for External Use in 2021
Figure 66. Manufacturing Process Analysis of Drugs for External Use
Figure 67. Industry Chain Structure of Drugs for External Use
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy